Psoriasis: News

• Study Links Obesity to Biologic Failure in Psoriasis A decade-long study finds that obesity is associated with a significantly increased risk for biologic treatment failure in patients with psoriasis.
  Medscape Medical News, April 07, 2025
• AAD 2025 TYK2 Inhibitors Show Impressive Efficacy for Psoriasis Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque psoriasis, with one producing a PASI90 response in 61% of patients at 52 weeks.
  Medscape Medical News, April 03, 2025
• Safety of Systemic Psoriasis Rxs Studied in Older Adults The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising concerns about the risks for step therapy protocols that may delay access to these options.
  Medscape Medical News, March 31, 2025
• HZ Risk With Psoriasis Biologics, Traditional Rxs Compared In a retrospective cohort study, ustekinumab and guselkumab show trends toward lower risk for herpes zoster in patients with psoriasis.
  Medscape Medical News, March 28, 2025
• AAD 2025 IL-23 Inhibitors Tested for Expanded Role in Psoriasis In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended remissions and protection against PsA relative to other biologics.
  Medscape Medical News, March 20, 2025
• Axial Involvement in PsA: What Are the Risk Factors? Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and HLA-B27 positivity associated with an increased risk for axial PsA.
  Medscape News UK, March 17, 2025
• AAD 2025 Significant Improvement in Psoriasis Seen With Oral Drug Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear skin, according to an interim analysis of a phase 3 trial.
  Medscape Medical News, March 17, 2025
• Diet Quality Is Linked to Psoriasis Severity in UK Study Individuals with decreased adherence to healthy dietary patterns are at least twice as likely to report high psoriasis severity.
  Medscape News UK, February 27, 2025
• Topical Psoriasis Treatment Options Show Robust Efficacy ‘Oftentimes, smaller local pharmacies are more familiar with newer topical medications,’ expert said.
  Medscape Medical News, February 25, 2025
• Teva Pharma and Alvotech Launch Biosimilar to J&J's Stelara in US Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug Stelara in the United States, the second in a...
  Reuters Health Information, February 21, 2025
• Does COVID-19 Worsen Skin Disease Outcomes? COVID-19 has little impact on patients with dermatological immune-mediated inflammatory diseases, with effective seroconversion after vaccination and few patients showing increased disease activity.
  Medscape News UK, February 20, 2025
• Bimekizumab Shows Sustained Benefits in Psoriasis Bimekizumab was well tolerated and complete skin clearance was maintained over 3 years of treatment in patients with moderate to severe plaque psoriasis, in a phase 3b trial.
  Medscape News UK, February 06, 2025
• High Pay, Low Stress: The Dermatology Boom Dermatology has become one of the most sought-after medical specialties, offering high salaries, good work-life balance, and low patient mortality.
  Medscape Medical News, January 30, 2025
• Psoriasis Tied to Higher Cardiovascular Risk in Delivery Women with psoriasis had increased risks for preeclampsia/eclampsia and cardiac arrhythmias during delivery hospitalizations, according to a real-world study evaluating maternal cardiovascular complication risks in this group of patients.
  Medscape Medical News, January 30, 2025
• Investigative Treatments for Moderate to Severe Psoriasis Reviewed Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered biologics.
  Medscape Medical News, January 29, 2025
• MauiDerm 2025 Like It or Not, Teledermatology Is Here to Stay “Don’t practice teledermatology on patients you’ve never seen before,” Dr. David J. Goldberg advised. “That’s the easiest way to stay out of trouble.”
  Medscape Medical News, January 23, 2025
• Around 5% of US Population Diagnosed With Autoimmune Disease A new analysis tool estimated that over 15 million individuals in the United States were affected with autoimmune diseases in 2022, with women representing the majority of the cases.
  Medscape Medical News, January 13, 2025
• New Ideas on PsA Pathogenesis May Drive New Treatments Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may become altered, leading to a worsening of symptoms.
  Medscape Medical News, January 07, 2025
• Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have cardiovascular and thrombotic risk profiles comparable with those of TNF inhibitors.
  Medscape Medical News, January 07, 2025
• Combined Psoriasis/PsA Clinics: Potential and Pitfalls Experts propose potential workarounds for obstacles to wider use of combined clinics and personalized medicine for dermatology and rheumatology patients.
  Medscape Medical News, January 02, 2025